|
1
|
Sugimachi K, Matsuura H, Kai H, Kanematsu
T, Inokuchi K and Jingu K: Prognostic factors of esophageal
carcinoma: univariate and multivariate analyses. J Surg Oncol.
31:108–112. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Natsugoe S, Matsumoto M, Okumura H, et al:
Prognostic factors in patients with submucosal esophageal cancer. J
Gastrointest Surg. 8:631–635. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Richardson HE, Stueland CS, Thomas J,
Russell P and Reed SI: Human cDNAs encoding homologs of the small
p34Cdc28/Cdc2-associated protein of Saccharomyces
cerevisiae and Schizosaccharomyces pombe. Genes Dev.
4:1332–1344. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bourne Y, Watson MH, Hickey MJ, et al:
Crystal structure and mutational analysis of the human CDK2 kinase
complex with cell cycle-regulatory protein CksHs1. Cell.
84:863–874. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ganoth D, Bornstein G, Ko TK, et al: The
cell-cycle regulatory protein Cks1 is required for
SCFSkp2-mediated ubiquitinylation of p27. Nat Cell Biol.
3:321–324. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Spruck CH, de Miguel MP, Smith AP, et al:
Requirement of Cks2 for the first metaphase/anaphase transition of
mammalian meiosis. Science. 300:647–650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spruck C, Strohmaier H, Watson M, et al: A
CDK-independent function of mammalian Cks1: targeting of
SCFSkp2 to the CDK inhibitor p27Kip1. Mol
Cell. 7:639–650. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tedesco D, Lukas J and Reed SI: The
pRb-related protein p130 is regulated by phosphorylation-dependent
proteolysis via the protein-ubiquitin ligase SCFSkp2.
Genes Dev. 16:2946–2957. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Masuda TA, Inoue H, Sonoda H, et al:
Clinical and biological significance of S-phase
kinase-associated protein 2 (Skp2) gene expression in gastric
carcinoma: modulation of malignant phenotype by Skp2
overexpression, possibly via p27 proteolysis. Cancer Res.
62:3819–3825. 2002.PubMed/NCBI
|
|
10
|
Welcker M, Orian A, Jin J, et al: The Fbw7
tumor suppressor regulates glycogen synthase kinase 3
phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad
Sci USA. 101:9085–9090. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Inui N, Kitagawa K, Miwa S, et al: High
expression of Cks1 in human non-small cell lung carcinomas. Biochem
Biophys Res Commun. 303:978–984. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wong YF, Cheung TH, Tsao GS, et al:
Genome-wide gene expression profiling of cervical cancer in Hong
Kong women by oligonucleotide microarray. Int J Cancer.
118:2461–2469. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lan Y, Zhang Y, Wang J, Lin C, Ittmann MM
and Wang F: Aberrant expression of Cks1 and Cks2 contributes to
prostate tumorigenesis by promoting proliferation and inhibiting
programmed cell death. Int J Cancer. 123:543–551. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang XC, Tian J, Tian LL, et al: Role of
Cks1 amplification and overexpression in breast cancer. Biochem
Biophys Res Commun. 379:1107–1113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sobin LH and Fleming ID: TNM
Classification of Malignant Tumors, fifth edition (1997). Union
Internationale Contre le Cancer and the American Joint Committee on
Cancer. Cancer. 80:1803–1804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arigami T, Natsugoe S, Uenosono Y, et al:
Lymphatic invasion using D2–40 monoclonal antibody and its
relationship to lymph node micrometastasis in pN0 gastric cancer.
Br J Cancer. 93:688–693. 2005.
|
|
17
|
Ogawa K, Utsunomiya T, Mimori K, et al:
Clinical significance of human kallikrein gene 6 messenger RNA
expression in colorectal cancer. Clin Cancer Res. 11:2889–2893.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Uchikado Y, Inoue H, Haraguchi N, et al:
Gene expression profiling of lymph node metastasis by
oligomicroarray analysis using laser microdissection in esophageal
squamous cell carcinoma. Int J Oncol. 29:1337–1347. 2006.PubMed/NCBI
|
|
19
|
Kita Y, Mimori K, Iwatsuki M, et al:
STC2: a predictive marker for lymph node metastasis in
esophageal squamous-cell carcinoma. Ann Surg Oncol. 18:261–272.
2011. View Article : Google Scholar
|
|
20
|
Tanaka F, Matsuzaki S, Mimori K, Kita Y,
Inoue H and Mori M: Clinicopathological and biological significance
of CDC28 protein kinase regulatory subunit 2 overexpression
in human gastric cancer. Int J Oncol. 39:361–372. 2011.PubMed/NCBI
|
|
21
|
Li M, Lin YM, Hasegawa S, et al: Genes
associated with liver metastasis of colon cancer, identified by
genome-wide cDNA microarray. Int J Oncol. 24:305–312.
2004.PubMed/NCBI
|
|
22
|
Kawakami K, Enokida H, Tachiwada T, et al:
Identification of differentially expressed genes in human bladder
cancer through genome-wide gene expression profiling. Oncol Rep.
16:521–531. 2006.PubMed/NCBI
|
|
23
|
Chen R, Feng C and Xu Y: Cyclin-dependent
kinase-associated protein Cks2 is associated with bladder cancer
progression. J Int Med Res. 39:533–540. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang JJ, Fang ZX, Ye HM, et al: Clinical
significance of overexpressed cyclin-dependent kinase subunits 1
and 2 in esophageal carcinoma. Dis Esophagus. 26:729–736.
2013.PubMed/NCBI
|
|
25
|
de Wit NJ, Rijntjes J, Diepstra JH, et al:
Analysis of differential gene expression in human melanocytic
tumour lesions by custom made oligonucleotide arrays. Br J Cancer.
92:2249–2261. 2005.PubMed/NCBI
|
|
26
|
Rickman DS, Bobek MP, Misek DE, et al:
Distinctive molecular profiles of high-grade and low-grade gliomas
based on oligonucleotide microarray analysis. Cancer Res.
61:6885–6891. 2001.PubMed/NCBI
|
|
27
|
Scrideli CA, Carlotti CG Jr, Okamoto OK,
et al: Gene expression profile analysis of primary glioblastomas
and non-neoplastic brain tissue: identification of potential target
genes by oligonucleotide microarray and real-time quantitative PCR.
J Neurooncol. 88:281–291. 2008. View Article : Google Scholar
|
|
28
|
Baylin SB and Jones PA: A decade of
exploring the cancer epigenome - biological and translational
implications. Nat Rev Cancer. 11:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He L and Hannon GJ: MicroRNAs: small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fabbri M, Calore F, Paone A, Galli R and
Calin GA: Epigenetic regulation of miRNAs in cancer. Adv Exp Med
Biol. 754:137–148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lv M, Zhang X, Li M, et al: miR-26a and
its target CKS2 modulate cell growth and tumorigenesis of papillary
thyroid carcinoma. PLoS One. 8:e675912013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liberal V, Martinsson-Ahlzen HS, Liberal
J, et al: Cyclin-dependent kinase subunit (Cks) 1 or Cks2
overexpression overrides the DNA damage response barrier triggered
by activated oncoproteins. Proc Natl Acad Sci USA. 109:2754–2759.
2012. View Article : Google Scholar : PubMed/NCBI
|
